Skip to content
superstack
Draft entry. Written from the cited papers but not yet reviewed by a person. Check the references before relying on any claim.

Citrus bergamot

also Bergamot · Citrus bergamia · Bergamot polyphenolic fraction · BPF

Citrus bergamot is a flavonoid-rich extract of the bergamot orange, sold to lower cholesterol. Several small randomised trials found lower LDL cholesterol [1][2]. A 2026 meta-analysis of nine trials found modest improvements in blood pressure, glucose and insulin resistance, and rated trial results as inconsistent [3]. A network meta-analysis ranked it among the most effective LDL-lowering nutraceuticals [4].

One of the better-supported cholesterol nutraceuticals, but the trials are small and often built around different branded extracts.

A plant extract; no single structure to draw.
Human RCTs7 papers · 2013–2026 · 7 journals · 7 in humans
  • meta-analysis
  • RCT
  • trial
  • observational
  • preclinical / case
  • review / patent / other
  • retracted
2013 · RCT · Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia.2017 · RCT · Effects of 12-week supplementation of Citrus bergamia extracts-based formulation CitriCholess on cholesterol and body weight in older adults with dyslipidemia: a randomized, double-blind, placebo-controlled trial.2019 · RCT · Hypoglycemic and Hypolipemic Effects of a New Lecithin Formulation of Bergamot Polyphenolic Fraction: A Double Blind, Randomized, Placebo- Controlled Study.2022 · meta-analysis · A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults.2023 · RCT · Effect of Citrus bergamia extract on lipid profile: A combined in vitro and human study.2024 · RCT · Citrus bergamia Extract, a Natural Approach for Cholesterol and Lipid Metabolism Management: A Randomized, Double-Blind Placebo-Controlled Clinical Trial.2026 · meta-analysis · Bergamot (Citrus bergamia) Supplementation and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.
in its favour
  • + Lowered LDL cholesterol in several randomised trials
  • + Ranked near the top of LDL-lowering nutraceuticals
  • + Added LDL lowering on top of a statin in one trial
watch for
  • Trials are small and use different branded extracts
  • Results across trials are inconsistent
  • Evidence is on blood markers, not heart attacks or strokes

Overview

Bergamot (Citrus bergamia) is a citrus fruit. Supplements use standardised extracts rich in flavonoids, often sold as a bergamot polyphenolic fraction (BPF).

The trials are consistent in direction but small. In 64 people with high cholesterol, a flavonoid extract taken for four months lowered total cholesterol by 8.8% and LDL by 11.5% [1]. In 50 moderately hypercholesterolaemic adults, a whole-fruit extract lowered total cholesterol, LDL, triglycerides, apolipoprotein B and fasting glucose over 12 weeks [2]. In older adults with dyslipidaemia, a bergamot formulation lowered LDL and body weight slightly [5]. Standard BPF and a lecithin formulation both lowered glucose, LDL and triglycerides and reduced small, dense LDL particles [6].

Pooled results are more cautious. A 2026 meta-analysis of nine trials (615 people) found small reductions in waist size, systolic pressure, glucose and insulin resistance, and described the trial results as inconsistent [3]. A network meta-analysis of 131 nutraceutical trials ranked bergamot and red yeast rice as the most effective at lowering LDL [4].

Mechanism

In human liver cells, one bergamot extract activated AMPK. It reduced the cells' cholesterol and triglyceride content and lowered the expression of lipid-synthesis genes, including HMGCR (HMG-CoA reductase) [2].

Direct targetswhat the molecule itself binds or acts on
  • AMPK in liver cellsactivates
    activated AMPK and reduced cholesterol and triglyceride content in human liver cells [2]
    unclear
Downstreamconsequences of that action, not targets of their own
  • Hepatic lipid synthesis genesblocks
    lowered expression of HMGCR, SREBF2 and FASN in liver cells [2]
    unclear

Safety

risks and cautions, not medical advice

In the four-month trial, weight, blood pressure and liver and kidney markers did not change, which the authors took as good tolerability [1]. Longer safety data is lacking.

Adverse effects
reported, not universal
  • No changes in liver or kidney markers in a four-month trial [1]
Cautions
who should think twice
  • Tell your doctor if you take a statin; bergamot added to its LDL-lowering effect in a trial [7]
Limits of the evidence
what has not been shown
  • Trials are small, short and use different proprietary extracts, so results do not pool cleanly [3]
  • All outcomes in the cited trials are blood markers, not heart attacks or strokes
  • Several trials were designed around a specific commercial product [2][5]

Interactions

documented pairs only, not exhaustive

In one trial in people with high cholesterol, adding BPF to rosuvastatin lowered LDL further than rosuvastatin alone [7]. That was studied as intended combined therapy. Anyone on a statin should still tell their doctor before adding it.

FAQ

Does bergamot lower cholesterol?
Small randomised trials found LDL reductions of around 10% [1], and a network meta-analysis ranked it among the most effective nutraceuticals for LDL [4].
Can it replace a statin?
None of the trials cited here tested that. One found it added to a statin's effect on LDL [7].

References

entry last reviewed 2026-09-18
  1. [1]
  2. [2]
    Effect of Citrus bergamia extract on lipid profile: A combined in vitro and human study.
    Pierdomenico M, Cicero AFG, Veronesi M et al.Phytother Res 2023RCT · humanPMID 37312672◌ unreviewed
  3. [3]
    Bergamot (Citrus bergamia) Supplementation and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.
    Chambari M, Mardani H, Roshandel M et al.Food Sci Nutr 2026meta-analysis · humanPMID 42746152◌ unreviewed
  4. [4]
    A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults.
    Osadnik T, Goławski M, Lewandowski P et al.Pharmacol Res 2022meta-analysis · humanPMID 35988871◌ unreviewed
  5. [5]
  6. [6]
    Hypoglycemic and Hypolipemic Effects of a New Lecithin Formulation of Bergamot Polyphenolic Fraction: A Double Blind, Randomized, Placebo- Controlled Study.
    Mollace V, Scicchitano M, Paone S et al.Endocr Metab Immune Disord Drug Targets 2019RCT · humanPMID 30501605◌ unreviewed
  7. [7]